Benzothiazepine derivatives for the treatment of hyperlipidaemia

Details for Australian Patent Application No. 2002331927 (hide)

Owner AstraZeneca AB

Inventors Dahlstrom, Mikael Ulf Johan; Blomberg, David; Starke, Ingemar

Agent Davies Collison Cave

Pub. Number AU-B-2002331927

PCT Number PCT/GB02/04043

PCT Pub. Number WO2003/022825

Priority 0121621.7 07.09.01 GB

Filing date 5 September 2002

Wipo publication date 24 March 2003

Acceptance publication date 21 February 2008

International Classifications

C07D 281/10 (2006.01) Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms

A61K 31/255 (2006.01)

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/554 (2006.01) - having at least one nitrogen and at least one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

Event Publications

6 February 2003 Complete Application Filed

  Priority application(s): 0121621.7 07.09.01 GB

19 June 2003 Application Open to Public Inspection

  Published as AU-B-2002331927

21 February 2008 Application Accepted

  Published as AU-B-2002331927

5 June 2008 Assignment before Grant

  AstraZeneca AB The application has been assigned to Albireo AB

19 June 2008 Standard Patent Sealed

2 April 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002331928-Carbazole derivatives and their use as NPY5 receptor antagonists

2002331926-METHODS AND SYSTEMS FOR ONESTOP COMMUNICATIONS MANAGEMENT